Top Companies in Transcatheter Aortic Valve Replacement Market by Size, Share, Historical and Future Data & CAGR | Report by Vantage Market Research
Transcatheter Aortic Valve Replacement Market is projected to reach a value of USD 8.8 Billion by 2030 at a CAGR of 7% over the forecast period.
Vantage Market Research has recently published a new report on "Transcatheter Aortic Valve Replacement Market” Global Industry Assessment & Forecast to identify key trends and challenges. The report offers insights into the competitive landscape, prospects, and key investment considerations for businesses operating in Transcatheter Aortic Valve Replacement market. Some of the key statistics in the report highlight that Global Transcatheter Aortic Valve Replacement Market was valued at USD 5.5 Billion in 2022 and is projected to reach a value of USD 8.8 Billion by 2030 at a CAGR of 7% over the forecast period. The global Transcatheter Aortic Valve Replacement market will continue to expand due to the rising geriatric population at risk for cardiovascular illnesses and the increasing desire for minimally invasive procedures.
Request Sample Report of Transcatheter Aortic Valve Replacement Market @ https://www.vantagemarketresearch.com/transcatheter-aortic-valve-replacement-market-2105/request-sample
The Global Transcatheter Aortic Valve Replacement Market is dominated by well-known players like Edwards Lifesciences Corporation (U.S.), Medtronic PLC (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), JenaValve Technology Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India), Micro Interventional Devices, Inc. (U.S.), Bracco SPA (Italy), Colibri Heart Valve LLC (U.S.), Transcatheter Technologies GmbH (Germany).
Let’s Take a Look at the Top Market Players that are Captivating the Transcatheter Aortic Valve Replacement Market
- Edwards Lifesciences Corporation (U.S.)
The business develops, produces, and markets devices for structural heart disease, critical care, and surgical monitoring. It is a medical technology company. The company sells transcatheter heart valves, pressure monitoring equipment, hemodynamic monitoring equipment, surgical valve replacement, repair devices, and other tools and accessories. The management of clotting, hypotension, and sepsis, as well as transcatheter aortic valve replacement (TAVR), blood conservation, infection control, and improved surgical recovery, are just a few therapies used by its products.
- Medtronic PLC (Ireland)
The business provides a comprehensive selection of medical goods and treatments in numerous therapeutic fields, such as diabetes, neurology, and cardiology. For example, Medtronic offers a range of cardiology products, including TAVR systems like the CoreValve Evolut and the Evolut PRO, for treating heart disease.
- Boston Scientific Corporation (U.S.)
The company creates, produces, and sells minimally invasive medical equipment. Products from the company are utilized in neuromodulation, endoscopy, urology, gynaecology, peripheral treatments, electrophysiology, cardiac rhythm control, and neurovascular intervention.
- Abbott Laboratories (U.S.)
The business finds, develops, produces, and markets various healthcare goods, such as branded generic medications, diagnostic tools and procedures, and infant and adult nutritional supplements. The business also sells a range of medical devices, such as those for neuromodulation, electrophysiology, rhythm control, vascular and structural cardiac devices, and heart failure.
- JenaValve Technology Inc. (U.S.)
The company produces and sells medical equipment. The business creates and produces systems for transapical, transcatheter aortic valve implantation. The JenaValve Pericardial TAVR System is the company's primary offering. The company serves customers worldwide.
- Meril Life Sciences Pvt. Ltd. (India)
They provide medical equipment in several therapeutic fields, including cardiology. For example, Meril offers a range of TAVR solutions, including the MyVal Transcatheter Heart Valve System, in the cardiology market to treat heart disease.
- Micro Interventional Devices Inc. (U.S.)
The company's primary offering is MIA (Minimally Invasive Annuloplasty) technology, intended to offer patients with mitral valve regurgitation a less invasive treatment option. In addition, MID's Transcatheter Cardiac Repair (TCR) platform is also designed to treat structural heart disease while the heart is beating, obviating the need for cardiopulmonary bypass. MID has created a patented, quickly deployable anchoring system called PolyCorTM that is only used in soft tissue applications. On the tip of a catheter, surgeons and interventionalists can carry out structural heart treatments that ordinarily need open surgery thanks to cutting-edge technology.
- Bracco SPA (Italy)
Bracco SpA is a privately held Italian business specializing in medical equipment and diagnostic imaging goods. Bracco develops novel medical devices, notably those for treating cardiac disease, in addition to its imaging equipment; the company's TAVR system is referred to as the BravaValve.
- Colibri Heart Valve LLC (U.S.)
It is a privately held medical device firm conducting research and producing patent-protected cutting-edge structural cardiac technologies. In addition, the business creates trans-catheter aortic valve implantation and operation devices that are pre-mounted, pre-crimped, pre-packaged, and prepared for usage.
- Transcatheter Technologies GmbH (Germany)
Transcatheter Technologies GmbH is an expert in creating cutting-edge medical devices for treating structural heart disease, focusing on transcatheter valve repair and replacement technology. The business also works on the Transcatheter Aortic Valve Prosthesis, a cutting-edge TAVR system (TAVP).
Read Our Latest Blog: Top Companies in Textile Recycling Market
Do You Have Any Queries or Specific Requirements? You may enquire to our sales team before purchasing.
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: [email protected]
Website: Vantage Market Research